Boston Scientific Stock Forecast

Stock Price Forecast

According to 31 analysts polled by S&P Global, Boston Scientific stock has a consensus rating of "Buy" and an average price target of $62.69. The average 1-year stock price forecast is 45.45% higher than the current stock price, while the lowest is $44 (+2.09%) and the highest is $94 (+118.10%).

Price Target: $62.69 (+45.45%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$44	$62.69	$60	$94
Change	+2.09%	+45.45%	+39.21%	+118.10%

Analyst Ratings

The average analyst rating for Boston Scientific stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	22	21	20	18	18	18
Buy	9	7	7	8	8	8
Hold	2	4	4	5	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	33	32	31	31	31	31

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Newitter Truist Financial	Truist Financial	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Sep 9, 2026
Marie Thibault BTIG	BTIG	Buy Reiterates $60 → $56	Buy	Reiterates	$60 → $56	+29.93%	Sep 9, 2026
Travis Steed Bank of America Securities	Bank of America Securities	Buy Maintains $54	Buy	Maintains	$54	+25.29%	Sep 8, 2026
Joanne Wuensch Citi	Citi	Buy Reiterates $57	Buy	Reiterates	$57	+32.25%	Sep 8, 2026
Josh Jennings TD Cowen	TD Cowen	Buy Maintains $56	Buy	Maintains	$56	+29.93%	Sep 4, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

21.34B

from 20.07B

6.33%

from 20.07B

Revenue Next Year

22.33B

from 21.34B

4.61%

from 21.34B

EPS This Year

3.29

from 3.06

7.63%

from 3.06

EPS Next Year

3.43

from 3.29

4.25%

from 3.29

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	11.89B	12.68B	14.24B	16.75B	20.07B	21.34B
Revenue Growth	19.92%	6.68%	12.29%	17.61%	19.87%	6.33%
Gross Profit	8.13B	8.68B	9.85B	11.46B	13.81B	14.93B
Gross Margin	68.37%	68.44%	69.16%	68.41%	68.78%	69.96%
Operating Income	1.82B	2.03B	2.42B	3.00B	3.97B	5.96B
Net Income	1.04B	698.00M	1.59B	1.85B	2.90B	3.80B
EPS	-	-	-	-	3.06	3.29
EPS Growth	-	-	-	-	21.91%	7.63%
Forward PE	23.73	24.51	26.76	33.08	28.71	13.09
Free Cash Flow	2.65B	1.15B	1.85B	1.79B	3.24B	3.70B
No. Analysts	-	-	-	-	-	27

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	22.1B
Avg	21.3B
Low	20.9B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	10.1%
Avg	6.3%
Low	4.3%

EPS Forecast

Chart

EPS	2026	2027	2028
High	3.37
Avg	3.29
Low	3.16

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	10.1%
Avg	7.6%
Low	3.3%